First Page | Document Content | |
---|---|---|
Date: 2013-02-12 12:59:51Euphoriants Pharmacology Amphetamines Attention-deficit hyperactivity disorder Para-Methoxyamphetamine Methamphetamine Para-Methoxymethamphetamine MDMA Substituted amphetamine Monoamine oxidase inhibitors Medicine Chemistry | 032 PADIS FAQ WEB READY v3.inddAdd to Reading ListSource URL: www.albertahealthservices.caDownload Document from Source WebsiteFile Size: 1.008,03 KBShare Document on Facebook |
Addiction, 1139–1148 RESEARCH REPORT Ecstasy pill testing: harm minimization gone too far?DocID: 1q7gg - View Document | |
27 January 2015 Dangerous Superman-branded ‘ecstasy’ pills still available For: Directors of Public Health to forward to: DocID: 18q35 - View Document | |
Microsoft Word - Newsletter 26 February 2013DocID: 12gVe - View Document | |
Overdose The risk of ecstasy overdose is low; however it may cause strokes, heart failure, brain haemorrhage, heart attack, high fever or coma. Injecting increases the risk of overdoseDocID: Vuci - View Document | |
6 Ecstasy E, pills, eccy, XTC, MDMA, pingas, Adam, X Ecstasy is a derivative of methamphetamine (the active ingredient is 3, 4–DocID: UECi - View Document |